Skip to main content
Figure 1 | Retrovirology

Figure 1

From: The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice

Figure 1

In vivo infection of HTLV-1 in engrafted human PBMCs in hu-PBMC-NOG-spl mice. A. Live cells were gated on their forward and side light scatter characteristics, and then cell surface markers within the HLA-class I-positive population were analyzed. B. There tended to be higher frequencies of CD4-positive cells than CD8-positive cells. The numbers represent the percentage of the cell population within the HLA-class I-positive gate. C. Genomic PCR to confirm HTLV-1 infection. Genomic DNA was extracted from human CD4 and CD8-positive T cells recovered from the spleens of hu-PBMC-NOG-spl mice sacrificed 14 days post infection, and then a fragment of the HTLV-1 pX region was amplified. β-actin was used as a control. The lower limit of detection was one copy of HTLV-1 tax per 104 PBMCs. D. RT-PCR to confirm HTLV-1 infection. RNA was extracted from human CD4 and CD8-positive T cells recovered from the spleens of hu-PBMC-NOG-spl mice sacrificed 14 days post infection. cDNA was synthesized and amplified from HTLV-1 tax and the HBZ region as described previously [15]. GAPDH was used as a control.

Back to article page